Ono Pharmaceutical Co., Ltd. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
OPHLY Over the counter 2830 www.ono-pharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ono Pharmaceutical Co., Ltd.

Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea - Jun 23rd, 2025 2:00 am
Ionis Pharmaceuticals Partners With Japan-Based Ono Pharmaceutical For Rare Blood Disease Drug In Over $800 Million Deal - Mar 12th, 2025 7:56 am
Ionis Out-Licenses Rights for Rare Blood Cancer Drug to Ono - Mar 12th, 2025 5:54 am
FATE Q4 Earnings Beat, Autoimmunity, Oncology Programs in Focus - Mar 6th, 2025 7:04 am
Ono’s TGCT therapy wins FDA approval, challenging Daiichi Sankyo - Feb 17th, 2025 11:27 am